Jim Cramer - Mad MoneyAbCellera BiologicsABCLCOMMENTMay 16, 2022

They're okay. Shares have fallen, but the company makes money.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$7.81

Stock price when the opinion was issued

$5.24

As of Jun 12, 2026. Market Open.

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica Track your Stocks in your Watch List

You might be interested:

DON'T BUY

This biotech is purely speculative. He ain't playin'.

RISKY

It's a spec play, but he likes the biologics space.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Jim Cramer - Mad MoneyAbCellera BiologicsABCLCOMMENTMay 16, 2022

You might be interested:

AbCellera Biologics(ABCL)

AbCellera Biologics(ABCL)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Jim Cramer - Mad Money

Richard Orrell

Stockchase Insights

The Panic-Proof Portfolio (Stockchase Research)

Stan Wong